Pliant Therapeutics (PLRX) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 6, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about PLRX filings

Are insiders buying or selling Pliant Therapeutics Inc (PLRX) stock?

Neither. Pliant Therapeutics Inc (PLRX) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PLRX recently?

None. No member of Congress disclosed a PLRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PLRX smart-money data?

This summary uses filings available on Nov 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

15 funds hold a position.

Questions about PLRX filings

Are insiders buying or selling Pliant Therapeutics Inc (PLRX) stock?

Neither. Pliant Therapeutics Inc (PLRX) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PLRX recently?

None. No member of Congress disclosed a PLRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PLRX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Mar 11, 2026

Period ending

Dec 31, 2025

Earnings per share

Unavailable

EPS comparison unavailable

Revenue (FY)

$0.00

Year ended Dec 31, 2025 · SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	Not on file	No estimate	Not on file	Not on file
Jun 30, 2026Reported Aug 11, 2026	-$0.36est. -$0.34	-4.43%miss	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 11, 2026	-$0.32est. -$0.36	+10.60%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 11, 2026	-$0.35est. -$0.38	+6.53%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.43est. -$0.52	+17.97%beat	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 7, 2025	-$0.71est. -$0.62	-14.52%miss	Not on file	Not on file
Mar 31, 2025Reported May 8, 2025	-$0.92est. -$0.75	-22.67%miss	Not on file	Not on file
Dec 31, 2024Reported Mar 3, 2025	-$0.82est. -$0.96	+14.15%beat	$0.00 · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.85
High: $0.85
Low: $0.80
Prev close: $0.85
52-wk high: $1.82
52-wk low: $0.83
Mkt cap: $52.7M
ROE: -50.3%
Beta: 1.36
P/S: 3071.8x
P/B: 0.4x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $53M

Valuation

P/S3071.82
P/B0.36

Quality

Operating margin0.0%
ROE-50.3%
ROA-23.3%

Growth

Beta1.36

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

64%annualized

52-week range

$0.82

$0.83$1.81

20D support

$0.80recent floor

20D resistance

$1.03recent ceiling

Returns

5D -5.1%20D -18.4%60D -23.7%

Price vs moving averages

SMA20 -8.5%SMA50 -19.8%SMA200 -29.2%

Volume pace

0.88xvs prior 20D

Smart money at a glance

Filings to Nov 6, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about PLRX filings

Are insiders buying or selling Pliant Therapeutics Inc (PLRX) stock?

Neither. Pliant Therapeutics Inc (PLRX) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PLRX recently?

None. No member of Congress disclosed a PLRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PLRX smart-money data?

No recent filings found.

15 funds hold a position.

Questions about PLRX filings

Are insiders buying or selling Pliant Therapeutics Inc (PLRX) stock?

Neither. Pliant Therapeutics Inc (PLRX) insiders filed no open-market purchases or sales in the 90 days to Nov 6, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PLRX recently?

None. No member of Congress disclosed a PLRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this PLRX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Mar 11, 2026

Period ending

Dec 31, 2025

Earnings per share

Unavailable

EPS comparison unavailable

Revenue (FY)

$0.00

Year ended Dec 31, 2025 · SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 5, 2026	Not on file	No estimate	Not on file	Not on file
Jun 30, 2026Reported Aug 11, 2026	-$0.36est. -$0.34	-4.43%miss	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 11, 2026	-$0.32est. -$0.36	+10.60%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 11, 2026	-$0.35est. -$0.38	+6.53%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 6, 2025	-$0.43est. -$0.52	+17.97%beat	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 7, 2025	-$0.71est. -$0.62	-14.52%miss	Not on file	Not on file
Mar 31, 2025Reported May 8, 2025	-$0.92est. -$0.75	-22.67%miss	Not on file	Not on file
Dec 31, 2024Reported Mar 3, 2025	-$0.82est. -$0.96	+14.15%beat	$0.00 · FYSEC filing	No year-ago quarter

Open: $0.85
High: $0.85
Low: $0.80
Prev close: $0.85
52-wk high: $1.82
52-wk low: $0.83
Mkt cap: $52.7M
ROE: -50.3%
Beta: 1.36
P/S: 3071.8x
P/B: 0.4x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $53M

Valuation

P/S3071.82
P/B0.36

Quality

Operating margin0.0%
ROE-50.3%
ROA-23.3%

Growth

Beta1.36

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

32balanced

20D volatility

64%annualized

52-week range

$0.82

$0.83$1.81

20D support

$0.80recent floor

20D resistance

$1.03recent ceiling

Returns

5D -5.1%20D -18.4%60D -23.7%

Price vs moving averages

SMA20 -8.5%SMA50 -19.8%SMA200 -29.2%

Volume pace

0.88xvs prior 20D

Pliant Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about PLRX filings

Questions about PLRX filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Pliant Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about PLRX filings

Questions about PLRX filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Pliant Therapeutics Inc

Overview

Questions about PLRX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Pliant Therapeutics Inc

Overview

Questions about PLRX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.